Abstract
Utilizing a polymorphism ratio sequencing platform, we performed a complete somatic mutation analysis of the mitochondrial D-loop region in 14 urothelial cell carcinomas. A total of 28 somatic mutations, all heteroplasmic, were detected in 8 of 14 individuals (57.1 %). Insertion/deletion changes in unstable mono- and dinucleotide repeat segments comprise the most pervasive class of mutations (9 of 28), while two recurring single-base substitution loci were identified. Seven variants, mostly insertion/deletions, represent population shifts from a heteroplasmic germline toward dominance in the tumor. In four cases, DNA from matched urine samples was similarly analyzed, with all somatic variants present in associated tumors readily detectable in the bodily fluid. Consistent with previous findings, mutant populations in urine were similar to those detected in tumor and in three of four cases were more prominent in urine.
Key messages
-
PRS accurately detects high mtDNA mutations in UCCs and their body fluids.
-
mtDNA mutations are universally heteroplasmic and often appear at low levels.
-
The PRS technology could be a viable approach to develop mitochondrial biomarkers.
Similar content being viewed by others
References
Jiang X, Wang X (2004) Cytochrome C-mediated apoptosis. Annu Rev Biochem 73:87–106
Warburg O (1956) On the origin of cancer cells. Science 123:309–314
Chatterjee A, Dasgupta S, Sidransky D (2011) Mitochondrial subversion in cancer. Can Prev Res 4:638–654
Dasgupta S, Hoque MO, Upadhyay S, Sidransky D (2008) Mitochondrial cytochrome B gene mutation promotes tumor growth in bladder cancer. Cancer Res 68:700–706
Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, Nakada K, Honma Y, Hayashi J (2008) ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320:661–664
Dasgupta S, Soudry E, Mukhopadhyay N, Shao C, Yee J, Lam S, Lam W, Zhang W, Gazdar AF, Fisher PB et al (2012) Mitochondrial DNA mutations in respiratory complex-I in never-smoker lung cancer patients contribute to lung cancer progression and associated with EGFR gene mutation. J Cell Physiol 227:2451–2460
Wallace DC (2005) A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 39:357–407
Kujoth GC, Leeuwenburgh C, Prolla TA (2006) Mitochondrial DNA mutations and apoptosis in mammalian aging. Cancer Res 66:7386–7389
Mecocci P, MacGarvey U, Beal MF (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease. Ann Neurol 36:747–751
Blazej RG, Paegel BM, Mathies RA (2003) Polymorphism ratio sequencing: a new approach for single nucleotide polymorphism discovery and genotyping. Genome Res 13:287–293
www.cancer.gov. Data accessed 11 November 2015
Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, Jen J, Sidransky D (2000) Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287:2017–2019
Dasgupta S, Shao C, Keane TE, Duberow DP, Mathies RA, Fisher PB, Kiemeney LA, Sidransky D (2012) Detection of mitochondrial DNA alterations in urine from urothelial cell carcinoma patients. Int J Cancer 131:158–164
Simpson PC, Roach D, Woolley AT, Thorsen T, Johnston R, Sensabaugh GF, Mathies RA (1998) High-throughput genetic analysis using microfabricated 96-sample capillary array electrophoresis microplates. Proc Natl Acad Sci USA 95:2256–2261
Paegel BM, Emrich CA, Wedemayer GJ, Scherer JR, Mathies RA (2002) High throughput DNA sequencing with a microfabricated 96-lane capillary array electrophoresis bioprocessor. Proc Natl Acad Sci USA 99:574–579
Woolley AT, Sensabaugh GF, Mathies RA (1997) High-speed DNA genotyping using microfabricated capillary array electrophoresis chips. Anal Chem 169:2181–2186
Mithani SK, Taube JM, Zhou S, Smith IM, Koch WM, Westra WH, Califano JA (2007) Mitochondrial mutations are a late event in the progression of head and neck squamous cell cancer. Clin Cancer Res 13:4331–4335
Hoque MO, Lee J, Begum S, Yamashita K, Engles JM, Schoenberg M, Westra WH, Sidransky D (2003) High-throughput molecular analysis of urine sediment for the detection of bladder cancer by high-density single-nucleotide polymorphism array. Cancer Res 63:5723–5726
Rieder MJ, Taylor SL, Tobe VO, Nickerson DA (1998) Automating the identification of DNA variations using quality-based fluorescence re-sequencing: analysis of the human mitochondrial genome. Nucleic Acids Res 26:967–973
Ju J, Ruan C, Fuller CW, Glazer AN, Mathies RA (1995) Fluorescence energy transfer dye-labeled primers for DNA sequencing and analysis. Proc Natl Acad Sci USA 92:4347–4351
Hjertén S (1985) High-performance electrophoresis: elimination of electroendosmosis and solute adsorption. J Chromatog 347:191–198
Scherer JR, Paegel BM, Wedemayer GJ, Emrich CA, Lo J, Medintz IL, Mathies RA (2001) High-pressure gel loader for capillary array electrophoresis microchannel plates. Biotechniques 31:1150–1152
Shi Y, Simpson PC, Scherer JR, Wexler D, Skibola C, Smith MT, Mathies RA (1999) Radial capillary array electrophoresis microplate and scanner for high-performance nucleic acid analysis. Anal Chem 71:5354–5361
Woolley AT, Hadley D, Landre P, deMello AJ, Mathies RA, Northrup MA (1996) Functional integration of PCR amplification and capillary electrophoresis in a microfabricated DNA analysis device. Anal Chem 68:4081–4086
Thaitrong N, Toriello NM, Del Bueno N, Mathies RA (2009) Polymerase chain reaction-capillary electrophoresis genetic analysis microdevice with in-line affinity capture sample injection. Anal Chem 81:1371–1377
Toriello NM, Liu CN, Blazej RG, Thaitrong N, Mathies RA (2007) Integrated affinity capture, purification, and capillary electrophoresis microdevice for quantitative double-stranded DNA analysis. Anal Chem 79:8549–8556
Emrich CA, Tian H, Medintz IL, Mathies RA (2002) Microfabricated 384-lane capillary array electrophoresis bioanalyzer for ultrahigh-throughput genetic analysis. Anal Chem 74:5076–5083
Ruiz-Pesini E, Lott MT, Procaccio V, Poole JC, Brandon MC, Mishmar D, Yi C, Kreuziger J, Baldi P, Wallace DC (2007) An enhanced MITOMAP with a global mtDNA mutational phylogeny. Nucleic Acids Res 35(Database issue):D823–D828, http://www.mitomap.org/
Williams C, Pontén F, Moberg C, Söderkvist P, Uhlén M, Pontén J, Sitbon G, Lundeberg J (1999) A high frequency of sequence alterations is due to formalin fixation of archival specimens. Am J Pathol 155:1467–1471
Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, Howell N (1999) Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet 23:147
Sun W, Zhou S, Chang SS, McFate T, Verma A, Califano JA (2009) Mitochondrial mutations contribute to HIF1α accumulation via increased reactive oxygen species and up-regulated pyruvate dehydrogenease kinase 2 in head and neck squamous cell carcinoma. Clin Cancer Res 15:476–484
Zhou S, Kachhap S, Sun W, Wu G, Chuang A, Poeta L, Grumbine L, Mithani SK, Chatterjee A, Koch W et al (2007) Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck. Proc Natl Acad Sci USA 104:7540–7545
Tan DJ, Bai RK, Wong LJC (2002) Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res 62:972–976
Nagy A, Wilhelm M, Sükösd F, Ljungberg B, Kovacs G (2002) Somatic mitochondrial DNA mutations in human chromophobe renal cell carcinomas. Genes Chromosomes Cancer 35:256–260
Polyak K, Li Y, Zhu H, Lengauer C, Willson JK, Markowitz SD, Trush MA, Kinzler KW, Vogelstein B (1998) Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet 20:291–293
Hibi K, Nakayama H, Yamazaki T, Takase T, Taguchi M, Kasai Y, Ito K, Akiyama S, Nakao A (2001) Detection of mitochondrial DNA alterations in primary tumors and corresponding serum of colorectal cancer patients. Int J Cancer 94:429–431
Jones JB, Song JJ, Hempen PM, Parmigiani G, Hruban RH, Kern SE (2001) Detection of mitochondrial DNA mutations in pancreatic cancer offers a “mass”-ive advantage over detection of nuclear DNA mutations. Cancer Res 61:1299–1304
Wong LJC, Lueth M, Li XN, Lau CC, Vogel H (2003) Detection of mitochondrial DNA mutations in the tumor and cerebrospinal fluid of medulloblastoma patients. Cancer Res 63:3866–3871
Jakupciak JP, Wang W, Markowitz ME, Ally D, Coble M, Srivastava S, Maitra A, Barker PE, Sidransky D, O’Connell CD (2005) Mitochondrial DNA as a cancer biomarker. J Mol Diagn 7:258–267
Liu VW, Shi HH, Cheung AN, Chiu PM, Leung TW, Nagley P, Wong LC, Ngan HY (2001) High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res 61:5998–6001
Mithani SK, Smith IM, Topalian SL, Califano JA (2008) Nonsynonymous somatic mitochondrial mutations occur in the majority of cutaneous melanomas. Melanoma Res 18:214–219
Philley JV, Kannan A, Qin W, Sauter ER, Ikebe M, Hertweck KL, Troyer DA, Semmes OJ, Dasgupta S (2016) Complex-I alteration and enhanced mitochondrial fusion are associated with prostate cancer progression. J Cell Physiol 231:1364–1374
Nickerson DA, Tobe VO, Taylor SL (1997) PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res 25:2745–2751
Salas A, Yao YG, Macaulay V, Vega A, Carracedo A, Bandelt HJ (2005) A critical reassessment of the role of mitochondria in tumorigenesis. PLoS Med 2:e296
Blazej RG, Kumaresan P, Mathies RA (2006) Microfabricated bioprocessor for integrated nanoliter-scale Sanger DNA sequencing. Proc Natl Acad Sci USA 103:7240–7245
Blazej RG, Kumaresan P, Cronier SA, Mathies RA (2007) Inline injection microdevice for attomole-scale Sanger DNA sequencing. Anal Chem 79:4499–4506
Kumaresan P, Yang CJ, Cronier SA, Blazej RG, Mathies RA (2008) High-throughput single copy DNA amplification and cell analysis in engineered nanoliter droplets. Anal Chem 80:3522–3529
Acknowledgments
The authors gratefully acknowledge Nadia Del Bueno, Samantha Cronier, Numrin Thaitrong, Jim Scherer, Peng Liu, and Kanwar Singh for valuable consultation. The involvement of Jing Yi and Terry Speed from the UC Berkeley Statistics Department was central to the design of the automated PRS analysis software. Microfabrication was performed by Eric Chu at the UC Berkeley Microlab. This work was supported by NIH grants #HG03329, #CA77664, and #CA075115 (R.A.M.) and the University of Texas Health Science Center at Tyler, Texas (S.D.).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Author contribution
R.A.M., S.D., and D.S. designed the experiments. D.P.D. and M.B. performed research. R.A.M., S.D., D.S., M.O.H., D.P.D., and D.T. analyzed the data and provided materials. R.A.M., S.D., and D.S. designed the project, supervised research. R.A.M., S.D., D.S., M.O.H., D.P.D., D.T., and M.B. wrote the paper.
Conflict of interest statement
R.A.M. has a financial interest in a company (IntegenX Inc.) working on the commercialization of microchip sequencing technologies that may benefit from the results of this research. Others have declared no competing interest.
Rights and permissions
About this article
Cite this article
Duberow, D.P., Brait, M., Hoque, M.O. et al. High-performance detection of somatic D-loop mutation in urothelial cell carcinoma patients by polymorphism ratio sequencing. J Mol Med 94, 1015–1024 (2016). https://doi.org/10.1007/s00109-016-1407-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-016-1407-2